[LGND] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
01-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -183.19%
YoY- -124.32%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 45,663 90,043 56,157 50,464 33,375 27,995 29,267 34.48%
PBT 79,226 95,579 55,312 30,665 12,071 8,300 6,193 446.14%
Tax 11,864 22,419 10,033 37,675 3,645 2,242 1,114 383.36%
NP 67,362 73,160 45,279 -7,010 8,426 6,058 5,079 459.42%
Tax Rate -14.97% -23.46% -18.14% -122.86% -30.20% -27.01% -17.99% -
Total Cost -21,699 16,883 10,878 57,474 24,949 21,937 24,188 -
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 147.52 81.25 80.63 -13.89 25.25 21.64 17.35 316.04%
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS 3.19 3.45 2.13 -0.34 0.40 0.29 0.24 460.23%
EPS Diluted 2.80 2.99 1.83 -0.33 0.36 0.26 0.22 444.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.